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Mitochondria maintain cellular homeostasis by
coordinating ATP synthesis with metabolic activity,
redox signaling, and apoptosis. Excessive levels
of mitochondria-derived reactive oxygen species
(ROS) promote mitochondrial dysfunction, triggering
numerous metabolic disorders. However, the molec-
ular basis for the harmful effects of excessive ROS
formation is largely unknown. Here, we identify
a link between mitochondrial stress and ubiquitin-
dependent proteolysis, which supports cellular
surveillance both in Caenorhabditis elegans and hu-
mans. Worms defective in respiration with elevated
ROS levels are limited in turnover of a GFP-based
substrate protein, demonstrating that mitochon-
drial stress affects the ubiquitin/proteasome system
(UPS). Intriguingly, we observed similar proteolytic
defects for disease-causing IVD andCOX1mutations
associated with mitochondrial failure in humans.
Together, these results identify a conserved link
between mitochondrial metabolism and ubiquitin-
dependent proteostasis. Reduced UPS activity dur-
ing pathological conditions might potentiate disease
progression and thus provides a valuable target for
therapeutic intervention.
INTRODUCTION
In eukaryotic cells mitochondria are central for various cellular
processes including the generation of energy and the orches-
tration of anabolic and catabolic metabolism. Defects in mito-
chondrial homeostasis are closely linked to the development
of human pathologies such as cancer, neurodegenerative dis-
eases, type 2 diabetes, and additional metabolic disorders (Wal-
lace, 2005). While limited amounts of reactive oxygen species
(ROS) appear to exert health-promoting functions in diverse spe-642 Cell Metabolism 19, 642–652, April 1, 2014 ª2014 Elsevier Inc.cies (Ristow and Zarse, 2010), mitochondrial dysfunction and
protein damage are mainly caused by excessive formation of
ROS, which are byproducts of oxidative phosphorylation and
energy production in the form of ATP (Livnat-Levanon and Glick-
man, 2011; Tatsuta, 2009). Oxidative stress provoked by respira-
tion defects usually results in misfolding and aggregation of
mitochondrial proteins and finally leads to irreversible damage
of mitochondria (Tatsuta, 2009). Additionally, metabolic failure
in catabolic pathways can cause accumulation of intermediates
and biochemical stress within mitochondria (Sack and Finkel,
2012).
Several quality-control mechanisms have evolved to main-
tain functional mitochondria by eliminating damaged proteins
or even the entire organelle. Besides autophagic consumption
of damaged mitochondria (called mitophagy) (Ashrafi and
Schwarz, 2013), these mechanisms include different proteolytic
quality control pathways in all mitochondrial compartments.
One major system for protein degradation within mitochon-
dria is based on the AAA-proteases Oma1 and Yme1, which
mediate the turnover of inner mitochondrial membrane (IMM)
proteins (Tatsuta, 2009). The mitochondrial matrix harbors Lon
and ClpP proteases, and the latter is also discussed to be
part of the mitochondrial unfolded protein response (UPRmt)
(Matsushima and Kaguni, 2012). In contrast, selective turnover
of at least some outer mitochondrial membrane proteins
involves the UPS (Livnat-Levanon and Glickman, 2011).
Damaged proteins are marked with a polyubiquitin chain formed
by ubiquitin-activating enzymes (E1), ubiquitin-conjugating en-
zymes (E2), and ubiquitin protein ligases (E3) (Kerscher et al.,
2006). In fact, the recently described mitochondria-associated
degradation (MAD) pathway involves the ubiquitin-selective
chaperone Cdc48/p97 in retrotranslocation of substrates from
mitochondria for degradation by the 26S proteasome (Cohen
et al., 2008; Heo et al., 2010; Karbowski and Youle, 2011; Taylor
and Rutter, 2011). Upon high oxidative stress conditions, Cdc48
and UPS components including the E3 ligase HUWE1 are
recruited to the mitochondrial outer membrane (Cohen et al.,
2008; Heo et al., 2010; Taylor and Rutter, 2011). This network
of different mitochondrial quality control systems is tran-
scriptionally controlled by the UPRmt (Haynes and Ron, 2010;
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Figure 1. A Mutagenesis Screen to Identify Genes Involved in
UPS-Mediated Protein Turnover
(A) Outline of the mutagenesis screen performed on hermaphrodite worms
expressing the UPS reporter Psur-5::UbV-GFP.
(B) Fluorescence and Nomarski images of worms expressing Ub-GFP in
wild-type (WT) or hecd-1 mutant worms as indicated. Scale bar, 100 mm.
(C) Protein lysates of worms displayed in (B), including one additional allele
hecd-1(hh9), were analyzed by SDS-PAGE and immunoblotting against GFP
and tubulin as loading control.
Cell Metabolism
Mitochondrial Stress Affects UPS ActivityPellegrino et al., 2013); however, the coordination between
mitochondrial and cellular proteostasis pathways has not
been addressed so far.
Here, we identified a link between mitochondrial metabolism
and the UPS, which supports cellular surveillance. Inactivation
of gene products engaged in oxidative phosphorylation or mito-
chondrial metabolism results in stabilization of a GFP-based
substrate in the worm intestine, suggesting a yet-unknown influ-
ence emanating from mitochondria on ubiquitin-dependent pro-
teolysis in the cytosol. These defects in degradation are linked
to enhanced oxidative stress, since substrate stabilization can
be suppressed by antioxidants. Moreover, an increase in ROS
levels accumulating with acute depletion of mitochondrial gene
transcripts strictly correlates with reduced UPS activity. The
failure in ubiquitin-dependent proteolysis appears to be down-
stream of the ubiquitin conjugation process, because increased
proteasomal capacity is able to restore substrate turnover. Since
we show similar results in patient cell lines defective in mito-
chondrial metabolism, our findings support the idea that ROS-
induced changes in ubiquitin-mediated proteolysis contribute
to human mitochondrial pathology and might foster disease
progression.CRESULTS
A Genetic Screen for Proteolytic Defects Identifies the
E3 Ligase HECD-1
The UPS is central for the elimination of damaged proteins and
the maintenance of cellular proteostasis; however, the physio-
logical requirements for tissue function and organismal growth
remained unclear. To identify factors regulating protein turnover
in multicellular organisms, we used a well-established in vivo
degradation assay that monitors even minor defects in proteo-
stasis and stress response in C. elegans (Segref and Hoppe,
2012; Segref et al., 2011). This system is based on short-lived
ubiquitin-fusion proteins (called UFD substrates), and was
extensively applied to define fundamental mechanisms and,
importantly, physiologically relevant degradation pathways of
the UPS in single-celled studies (Johnson et al., 1995; Richly
et al., 2005). Worms expressing a GFP-based UFD substrate
UbV-GFP (Ub-GFP) under control of the ubiquitous sur-5 pro-
moter show no green fluorescence due to low steady-state
levels of the fusion protein enforced by polyubiquitylation of
the N-terminal ubiquitin moiety and subsequent rapid pro-
teasomal degradation. We used this reporter strain to monitor
proteolytic defects in a forward genetic screen, where similar
coexpression of the stable mCherry protein served as control
to exclude transcriptional and translational changes (Figure 1A).
Ten thousand worms were mutagenized using ethyl methane-
sulfonate (EMS) and screened in the F2 generation for viable,
GFP-positive mutants with increased Ub-GFP substrate levels
(Figure 1A). Only nonlethal mutations were examined in our
study, precluding disruption of essential functions such as pro-
teasomal integrity. Among others, we first focused on four mu-
tants with very strong and similar stabilization of GFP for further
characterization (hecd-1(hh2-4, hh9); see Table S1 available
online). A noncomplementation analysis revealed that these
mutants were not able to complement each other (Table S2),
andwhole-genome sequencing (WGS) of threemutants revealed
independent stop mutations in the same gene, called hecd-1
(Figure S1A). Additionally, a hecd-1(tm2371) deletion mutant
caused Ub-GFP stabilization in all tissues, which confirmed the
phenotype of the hecd-1 mutants identified in our screen (Fig-
ures 1B and 1C). Moreover, these mutants did not complement
the hecd-1 deletion mutant (Table S2). Thus, our forward genetic
screen identified HECD-1 as an important factor for ubiquitin-
dependent substrate turnover. In fact, HECD-1 is a HECT
domain-containing E3 ligase related to human HECtD1 and
HUWE (Leboucher et al., 2012).
Loss of Functional IVD-1 and ACS-19 Limits Ubiquitin-
Dependent Protein Degradation
In addition, our screen identified two other mutants with strong
stabilization of the Ub-GFP substrate, which are independent
of hecd-1 defects (ivd-1(hh6), acs-19(hh5); Table S1 and Table
S2). SNP mapping and WGS placed the mutations into a 3.96
and 3.6Mbp region on chromosomes III and IV, respectively (Fig-
ures S1B and S1C). RNAi against potential candidates revealed
that ivd-1(RNAi) and acs-19(RNAi) generate similar GFP stabili-
zation in the intestine compared to the ivd-1(hh6) and acs-
19(hh5) mutations found in the screen (Figures 2A–2C). The
mutation in ivd-1(hh6) causes a G-to-A splice donor mutationell Metabolism 19, 642–652, April 1, 2014 ª2014 Elsevier Inc. 643
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Figure 2. Mutations in ivd-1 and acs-19
Display Defects in Ub-GFP Turnover
(A) Fluorescence and Nomarski images of wild-
type (WT) or ivd-1(hh6)mutant worms and of wild-
type worms grown on control (RNAi) (ctrl (RNAi))
or ivd-1(RNAi) plates analyzed for stabilization of
Ub-GFP at day 1 of adulthood. Scale bar, 100 mm.
(B) As in (A), but acs-19(hh5) worms were
compared to WT and acs-19(RNAi). Scale bar,
100 mm.
(C) Western blot analysis of protein lysates derived
from day 1 adult worms expressing Ub-GFP as
indicated. The blot was probed against GFP and
tubulin as loading control.
(D) Fluorescence and Nomarski images of worms
expressing Ub-GFP in ivd-1(hh6) mutants with
or without the ivd-1 gene-containing fosmid
WRM061bH04 (ivd-1(hh6)+ivd-1). (Bottom) acs-
19(hh5) mutants without (acs-19(hh5)) or with the
acs-19 gene-containing fosmid WRM0620aH08
(acs-19(hh5)+ acs-19). Fluorescent images were
taken with the same exposure times. Scale bars,
100 mm.
(E) Lysates of day 1 adult worms expressing
Ub-GFP treated with RNAi against the C. elegans
orthologs of human branched-chain keto acid
dehydrogenase E1 (tag-173) and alpha methyl-
crotonyl coenzyme A carboxylase 1 (mccc-1)
involved in leucine catabolism were analyzed by
western blotting against GFP and tubulin.
(F) Worms expressing Ub-GFP were depleted by
RNAi for the indicated genes and analyzed by
western blotting as in (C).
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Mitochondrial Stress Affects UPS Activityof the second intron, creating an aberrantly spliced mRNA (Fig-
ure S1C). Consequently, sequencing of the ivd-1(hh6) cDNA
confirmed a deletion of 45 nucleotides of the second exon,
causing an in-frame deletion of 15 amino acids that are highly
conserved between different species including human IVD (Fig-
ure S1D). In the acs-19(hh5) mutant the conserved glycine resi-
due 311 (G311) is exchanged against arginine (R) (Figures S1B
and S1E). Thus, loss of important residues in the ivd-1 or acs-
19mutants together with the recessive nature in genetic comple-644 Cell Metabolism 19, 642–652, April 1, 2014 ª2014 Elsevier Inc.mentation studies suggest reduced pro-
tein functions. Accordingly, transgenic
expression of the respective wild-type
genes could rescue the proteolytic defect
of ivd-1(hh6) and acs-19(hh5)worms (Fig-
ure 2D and Figures S2A–S2C), indicating
that IVD-1 and ACS-19 activity are linked
to ubiquitin-dependent protein turnover.
IVD-1 is the ortholog of human isova-
leryl-CoA dehydrogenase (IVD) (Mohsen
et al., 2001), a mitochondrial enzyme
with a defined role in the leucine catabo-
lism pathway. During leucine degrada-
tion, IVD catalyzes the conversion of
isovaleryl-CoA into 3-methylcrotonyl-
CoA (Figure S2E) (Vockley and Ensena-
uer, 2006). We therefore asked if this
particular step during leucine degradationmight be important for turnover of the Ub-GFP substrate. RNAi
against predicted ortholog genes of human BCKDHB and
MCCC1 expected to act upstream or downstream, respectively,
of ivd-1 (Marcotte et al., 2000), revealed an accumulation of
Ub-GFP (Figures 2E and S2E), indicating that perturbance of
the mitochondrial leucine degradation pathway per se affects
ubiquitin-dependent protein turnover. ACS-19 is defined as
acetyl-CoA synthetase, the predicted ortholog to human ACSS2,
a cytosolic enzyme that catalyzes the conversion of acetate to
A B
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Figure 3. Protein Turnover in ivd-1, acs-19, or
hecd-1 Worms
(A) Worms expressing either CPL-1W32A, Y35A-YFP
(CPL-1W32A, Y35A) or Ub-GFP (UbV-GFP) were RNAi
treated as indicated and lysates of worms analyzed
by western blotting with an antibody against GFP
that also recognizes YFP (anti-GFP) and tubulin.
(B) Lysates of day 1 adult mutant worms were
analyzed for the presence of polyubiquitylated
substrates by western blotting against poly-
ubiquitin. As a control, cdc-48.1(tm544) mutants
were either treated with control (RNAi) or cdc-48.2
(RNAi).
(C) Relative ATP levels in day 1 wild-type (WT)
and mutant worms. Results display three (ivd-1,
hecd-1), five (WT), and four independent experi-
ments (acs-19), average ± SD. **p% 0.01.
(D) Relative slopes of chymotrypsin, trypsin, and
caspase-like proteasomal activity of day 1 wild-
type (WT) and mutant worms. Averages are dis-
played of five to seven independent experiments ±
SEM; p > 0.05.
(E) Hermaphrodites expressing either GFP
(GFP(OE)) or rpn-6.1 and GFP (rpn-6.1,GFP(OE))
on extrachromosomal arrays and integrated
sur-5::UbV-GFP were RNAi-treated and lysates
examined by western blotting as in Figure 2C.
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Mitochondrial Stress Affects UPS Activityacetyl-COA required for fatty acid cycle in the mitochondrial
matrix (Starai and Escalante-Semerena, 2004). In this regard it
is interesting that the human HECT E3 ligase HUWE1 is also
required for mitochondrial integrity, because it targets mitofusin
2 for proteasomal degradation (Leboucher et al., 2012). There-
fore, it is very likely that HECD-1 identified in our screen is also
involved in mitochondrial maintenance in worms. These data
indicate that our screen for UPS activity defects predominantly
identified mutants with diminished mitochondrial function.
Increased Proteasomal Activity Restores Substrate
Turnover in ivd-1 and acs-19 Mutants
To address the correlation between mitochondrial defects and
decreased UPS activity, we further evaluated the role of ivd-1,
acs-19, and hecd-1 in ubiquitin-dependent protein turnover.
Importantly, RNAi-mediated depletion of ivd-1, acs-19, and
hecd-1 had no effect on the amount of K29,48RUb-GFP, a stable
version of the substrate that cannot be polyubiquitylated, or of
GFP alone (Figure S2D). In contrast to loss of the E3 ligase
HECD-1, the UFD substrate accumulates as polyubiquitylated
forms in worms lacking IVD-1 or ACS-19 (Figure 2F). This com-
parison confirmed that the effects of ivd-1, acs-19, and hecd-1
on steady-state levels of Ub-GFP were due to diminished
UPS function. In contrast to proteolysis of Ub-GFP in theCell Metabolism 19, 642cytosol, ER-associated protein degrada-
tion (ERAD) is not affected (Figure 3A).
The ERAD substrate CPLW32A,Y35A (Miedel
et al., 2012) is only stabilized upon deple-
tion of the Hrd3 ligase homolog sel-1
(Grant and Greenwald, 1997), suggesting
that IVD-1, ACS-19, and HECD-1 do not
participate in ERAD (Figure 3A). Indeed,the ER chaperone hsp-4 was also not induced after ivd-1, acs-
19, or hecd-1 RNAi (Figure S3A). The expression level of HSP-
4 directly monitors defects in degradation of misfolded proteins
accumulating in the ER lumen (Urano et al., 2002). It would thus
appear that IVD-1, ACS-19, and HECD-1 are not relevant for ER
function. To investigate whether the mutants have an overall
defect in protein turnover, we analyzed the levels of polyubiqui-
tylated substrates and found them to be unchanged compared
to wild-type worms (Figure 3B). This is consistent with the fact
that these mutants are viable, whereas severe defects in the
UPS induced by codepletion of cdc-48.1 and cdc-48.2 lead to
strong stabilization of polyubiquitylated substrates and lethality
(Figure 3B) (Kuhlbrodt et al., 2011).
Since IVD-1, ACS-19, and HECD-1 seem to be linked to mito-
chondrial function, one explanation for the reduction in UPS ac-
tivity could be a decrease in ATP production, which would affect
E1-dependent ubiquitin activation and proteasomal degrada-
tion. However, measurement of the ATP levels in the ivd-1,
acs-19, and hecd-1mutants revealed no decrease in the general
ATP levels (Figure 3C). Thus, the defects in ubiquitin-dependent
protein turnover are not due to changes in ATP availability. Simi-
larly, the function of the 20S proteasome core particle is not
reduced, as revealed by measurements of chymotrypsin-,
trypsin-, and caspase-like activities (Figure 3D). We therefore–652, April 1, 2014 ª2014 Elsevier Inc. 645
AE
C D
B Figure 4. Cellular Stress Response by
Disruption of ivd-1, acs-19, or hecd-1 Func-
tion
(A) Hermaphrodites expressing sur-5::UbV-GFP or
sur-5::GFP were RNAi-treated against the indi-
cated genes and lysates of day 1 adult worms
subjected to western blotting against GFP and
tubulin.
(B) Hermaphrodites were RNAi treated against the
indicated genes and analyzed for the expression of
gst-4::GFP at day 1 adult stage. Western blotting
was performed as in Figure 2C.
(C) ROS levels of WT hermaphrodites (expressing
sur-5::UbV-GFP as control for RNAi efficiency)
that were treated with the indicated RNAi’s for
48 hr (control, acs-19, ivd-1). Data are averages
derived from two independent experiments ±
SEM; ***p% 0.001.
(D) H2O2 production measured by Amplex Red
staining of the strain used in (C) treated with RNAi
as indicated or antimycin A with or without
N-acetyl cysteine (NAC). Averages from two in-
dependent experiments ± SEM; ***p % 0.001,
*p % 0.05; () NAC compared to the control,
(+) NACwere compared to the (–) NAC counterpart
to indicate significant suppression by NAC.
(E) Mutant worms expressing sur-5::UbV-GFP
were grown on control plates (c) or plates con-
taining 10 mM NAC from L1 stage to day 1 of
adulthood. Western blotting was performed as in
Figure 2C; short exp. and long exp., short and long
exposure of the blot, respectively.
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Mitochondrial Stress Affects UPS Activityexamined if overexpression of the rpn-6 subunit, a component of
the 19S lid complex that was previously shown to increase as-
sembly and activity of the 26S proteasome, could suppress the
degradation defects of our mutants (Vilchez et al., 2012). Inter-
estingly, overexpression of rpn-6 could indeed suppress the
degradation defects of ivd-1 and acs-19 but not hecd-1 RNAi-
depleted worms (Figure 3E). This is consistent with the proposed
role of HECD-1 acting as an E3 ligase in substrate recognition
and suggests that the defects seen upon ivd-1 and acs-19 inac-
tivation occur downstream of substrate recognition.
Enhanced Oxidative Stress Correlates with Impaired
UPS Activity in Worms Lacking IVD-1, ACS-19, or
HECD-1
To evaluate the induction of stress responses, we analyzed the
levels of heat shock protein 70 (hsp70) homologs in the ivd-1,
acs-19, and hecd-1 mutants. Hsp-70 supports protein folding
in the cytosol, whereas HSP-6 facilitates mitochondrial import,
biogenesis, and energy generation (Kimura et al., 2007). How-
ever, we could not detect any increase in cytosolic HSP-70 or
mitochondrial HSP-6 levels (Figures S3B and S3C). Therefore,
we depleted key regulators of general stress pathways such as
SKN-1, DAF-16, or HIF-1 by RNAi and examined proteolytic de-
fects (Figure 4A) (An and Blackwell, 2003; Mehta et al., 2009;
Ogg et al., 1997). Interestingly, only downregulation of skn-1 re-
vealed a strong stabilization of the Ub-GFP substrate. Since
SKN-1 is the major transcription factor acting upon oxidative
stress (An and Blackwell, 2003), we examined whether the646 Cell Metabolism 19, 642–652, April 1, 2014 ª2014 Elsevier Inc.oxidative stress response is induced in worms lacking IVD-1,
ACS-19, and HECD-1. Indeed, ivd-1, acs-19, and hecd-1 RNAi
revealed an increase in the amount of the glutathione S-trans-
ferase GST-4, the expression of which is under tight control of
SKN-1 and thus reflects enhanced oxidative stress (Figure 4B)
(Kahn et al., 2008). Accordingly, acute depletion of ivd-1 or
acs-19 by RNAi revealed a transient increase in ROS production
(Figure 4C), whereas constitutive ivd-1 and acs-19 mutants
exhibit reduced ROS levels in the steady state (Figure S3D).
We reasoned that ivd-1 and acs-19mutants might have adjusted
to an initial accumulation of ROS due to a process called mito-
hormesis, which was also reported for impaired insulin signaling
by the DAF-2 receptor (Zarse et al., 2012). In further support of an
adaptive response mechanism, the ivd-1 and acs-19 mutants
exhibited reduced sensitivity upon treatment with antimycin A
(Figure S3E), which is a drug known to increase mitochondrial
ROS production (Chen et al., 2003). Conversely, hecd-1 mutant
animals are more sensitive to antimycin A (Figure S3E), consis-
tent with the fact that worms lack a transient ROS increase after
exposure to hecd-1 RNAi (data not shown) but mutant hecd-1
rather show increased ROS levels in the steady-state (Fig-
ure S3D). Importantly, the increased ROS level caused by ivd-1
and acs-19 depletion or antimycin A treatment can be efficiently
reduced by addition of the antioxidant N-acetyl cysteine (NAC)
(Figure 4D). Therefore, we wondered whether the observed
changes in ROS strictly correlate with reduced UPS activity.
Indeed, similar to the elevated ROS level, NAC also attenuated
the protein turnover defects in ivd-1, acs-19, and hecd-1
AC
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Figure 5. Disruption of Mitochondrial Function Impairs Ub-GFP
Turnover
(A)Wild-typewormsexpressing sur-5::UbV-GFPwere treatedwith the indicated
RNAis and lysates of worms examined by western blotting as in Figure 2C.
(B) Hermaphrodites expressing either GFP () (GFP(OE)) or rpn-6.1 andGFP (+)
(rpn-6.1,GFP(OE)) on extrachromosomal arrays and integrated sur-5::UbV-GFP
were RNAi treated and lysates examined by western blotting as in Figure 2C.
(C) Wild-type worms expressing sur-5::UbV-GFP were treated with the
indicated RNAis from L1 to adulthood and moved to control () or 10 mM
NAC-containing NGM plates (+) 24 hr prior to collection. Lysates of worms
were examined by western blotting as in Figure 2C.
(D) Fluorescence and Nomarski images of wild-type worms expressing
Ub-GFP either untreated (control), or treated with 3 mM rotenone, 2 mM anti-
mycin A, or 0.2 mM sodium azide (NaN3) for 12 hr. Scale bar, 1 mm.
(E) Lysates of worms displayed in (D) were analyzed by western blotting
against GFP and tubulin.
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Mitochondrial Stress Affects UPS Activitymutants (Figure 4E), suggesting a general link between oxidative
stress response in mitochondria and ubiquitin-dependent prote-
olysis in the cytosol.CInhibition of Oxidative Phosphorylation Affects
Ubiquitin-Dependent Degradation
Since our observations link ROS production with ubiquitin-
dependent protein turnover defects, we next wondered whether
mitochondrial dysfunction might be the underlying cause or con-
tributes to this inhibition. Therefore we analyzed the stabilization
of the Ub-GFP substrate upon RNAi depletion of critical compo-
nents important for oxidative phosphorylation. Indeed, inhibition
of respiratory chain function by downregulation of complex I
(gas-1, nuo-1, nuo-6), complex II (mev-1), complex III (isp-1),
and complex IV (cco-1) (Dingley et al., 2010; Tsang et al., 2001)
resulted in proteolytic failure in the cytosol (Figure 5A). Similarly,
disruption of mitochondrial fission by drp-1(RNAi) (Labrousse
et al., 1999) and mitochondrial UPR by hsp-60(RNAi) result in
strong stabilization of the GFP-based reporter substrate (Fig-
ure 5A). In contrast, RNAi against hsp-4 and hsp-12.6, major
chaperons involved in ER stress and heat-shock response,
respectively, had no effect, which indicates a specific crosstalk
between mitochondrial stress response and the UPS. As shown
for ivd-1 and acs-19 depletion, the degradation defect of mito-
chondrial respiration mutants can be restored by rpn-6 over-
expression or NAC treatment (Figures 3E, 4E, 5B, and 5C).
Moreover, treatment with antimycin A and sodium azide, two
drugs known to inhibit respiratory complex III and IV function
of mitochondria (Chen et al., 1999; Rotsaert et al., 2008), respec-
tively, also resulted in strong stabilization of Ub-GFP (Figures 5D
and 5E). In contrast, rotenone generating ROS at complex I
exclusively in the mitochondrial matrix (Sena and Chandel,
2012) did not cause defects in UFD substrate degradation.
Thus, oxidative and metabolic stress in mitochondria generally
affect ubiquitin-dependent protein turnover in the cytosol.
Reduced UPS Activity Is Linked to HumanMitochondrial
Disease Pathology
Our data strongly suggest that mitochondrial stress impairs UPS
activity inC. elegans. Therefore, we asked whether this observa-
tion reflects a conserved link betweenmitochondrial metabolism
and cellular ubiquitin-dependent proteostasis. To address this
question we used MelJuSo cell lines constitutively expressing
the UFD or N-end rule substrate (Mene´ndez-Benito et al.,
2005). Whereas the N-terminal ubiquitin serves as degradation
signal for the UFD substrate, deubiquitylation of N-end rule
substrates defines the half-life of the remaining protein, which
is related to the identity of its amino-terminal residue (Johnson
et al., 1995; Varshavsky, 1992). As in worms, treatment with anti-
mycin A resulted in strong stabilization of both ubiquitylated
substrates (Figures 5D, 5E, 6A, S4A, and S4B). In fact, this pro-
tein turnover defect can be restored by addition of NAC, indi-
cating that it is based on increased ROS level (Figure 6B).
Since mutations in the IVD gene encoding the human ortholog
of IVD-1 in nematodes cause an autosomal recessive disorder
called isovaleric acidemia (IVA), we were interested to study pri-
mary cells derived from IVA patients for defects in ubiquitin-
dependent protein turnover. Fibroblasts from a patient with a
severe phenotype (c.IVS4+2T > C) due to a homozygous splice
site mutation (c.IVS4+2T >C/c.IVS4+2T >C) are lacking IVD pro-
tein completely, whereas an individual with a milder metabolic
and clinical phenotype (c.932C > T) and homozygosity for a
missense mutation (c.932C > T/c.932C > T) (Ensenauer et al.,ell Metabolism 19, 642–652, April 1, 2014 ª2014 Elsevier Inc. 647
DE
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F
C
B Figure 6. Disease-Related Mitochondrial
Mutations Disrupt UPS-Mediated Protein
Turnover in Humans
(A) MelJuSo cell lines stably expressing UbR-YFP
or UbG76V-YFP were pretreated for 18 hr with
ethanol as control () or 100 mM antimycin A
(in ethanol) followed by 100 mg/ml cycloheximide
for the indicated time points. Cell lysates were
analyzed by western blotting against YFP and
tubulin.
(B) Cell lines from (A) were pretreated with H2O ()
or the indicated concentrations of N-acetylcys-
teine (NAC), followed by 18 hr incubation with
100 mM antimycin A with or without NAC. Cell
lysates were analyzed as in (A).
(C and D) Primary human control fibroblasts (C)
and fibroblasts from IVD-deficient patients with
a severe (c.IVS4+2T > C) or mild (c.932C > T)
phenotype were transfected with UbR-GFP or
UbG76V-GFP andmCherry as transfection control,
and cell lysates were analyzed by western blotting
against GFP, mCherry, and tubulin.
(E) Mitochondrial ROS content was measured in
fibroblast cells described in (C) using MitoSOX
staining. Mean fluorescence intensities normalized
to the average fluorescence measured in the con-
trol cell line are shownwith the SEM (c: 1.00 ± 0.04;
c.IVS4+2T >C: 1.59 ± 0.06 (***p% 0.001); c.932C >
T: 1.16 ± 0.06 (*p% 0.05)); (nc = 166; nc.IVS4+2T > C =
139; nc.932C > T = 132).
(F) Untransfected fibroblast cell lines as described
in (C) were analyzed by western blotting with anti-
bodies against Mfn2, Mcl1, and tubulin.
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ern blot analysis of cell lysates showed that the overall polyubi-
quitin levels are unchanged in severe and mild IVA patient cells
(Figure S4D). Interestingly, transfection of the IVA fibroblasts
with the N-end rule substrate revealed a strong stabilization of
UbR-GFP, especially in severe IVA patient cells (c.IVS4+2T > C)
(Figure 6C). Moreover, the UFD substrate accumulated exclu-
sively in c.IVS4+2T > C fibroblasts as compared to control (c) or
c.932C > T patient cells. The stabilization seen in fibroblasts
with the severe IVA phenotype (c.IVS4+2T > C) is similar to
treatment of control fibroblasts with the proteasomal inhibitor
bortezomib (Figure 6D). These turnover defects correlate with
increased ROS levels in the patient cells, with c.IVS4+2T > C ex-
hibiting higher oxidative stress (Figure 6E).We testedwhether the
stabilization of the UFD and N-end rule substrate reflects defects
in MAD. However, the levels of the OMM proteins mitofusin 2
(Mfn2) and Mcl1, important for mitochondrial fusion and
apoptosis (Chan et al., 2011; Tanaka et al., 2010; Xu et al.,
2011), did not increase in c.IVS4+2T > C patient cells (Figure 6F).
Thus, in addition to the previously identified accumulation of
metabolites (Table S3), patients suffering from IVA also display
defects in ubiquitin-dependent protein turnover,which correlates
with the degree of enzymatic impairment and disease pathology.
Similarly, substrate degradation was reduced in cybrid cells from648 Cell Metabolism 19, 642–652, April 1, 2014 ª2014 Elsevier Inc.patients with a defect in the COX1 gene
affecting respiratory complex I (G6930A)
(Bruno et al., 1999) (Figures S4E andS4F). Thus, it appears that, comparable toC. elegans, mitochon-
drial dysfunction also affects UPS activity in humans.
DISCUSSION
As defects in mitochondrial respiration are known to cause pro-
tein damage and mitochondrial dysfunction, the cytotoxic con-
sequences of ROS remained enigmatic. With regard to human
metabolic diseases it is particularly interesting how oxidative
stress affects mitochondrial homeostasis and cellular protein
quality control mechanisms. Here, we discovered a conserved
influence of respiration defects and mitochondrial stress condi-
tions on the efficiency of ubiquitin-dependent degradation
pathways in the cytosol both in C. elegans and humans. Acute
depletion of ivd-1 and acs-19 by RNAi caused a mild but signif-
icant increase in ROS, which correlates with defects in UFD
substrate turnover. Whereas the ROS levels of the originally
identified ivd-1 and acs-19 mutants are comparable to wild-
type worms or even decreased, the mutants are still limited in
substrate degradation. This discrepancy suggests that the
adaptation against an initial increase in ROS is not able to restore
protein turnover defects, probably by long-term changes of
respiratory and metabolic processes, and might support the
manifestation of chronic disorders (Figures 4C, 4D, and S3D).
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ysis in the Cytosol Supports Cellular Surveillance
(A) Lifespan analysis of worms as indicated grown at 20C on NGM containing
OP50. Detailed statistics are provided in Table S4.
(B) Damaged mitochondrial proteins accumulating upon high ROS levels are
degraded via the recently identified MAD pathway. This process involves the
stress-induced recruitment of the ubiquitin-selective chaperone Cdc48 to the
outer mitochondrial membrane, which facilitates the retrotranslocation and
targeting of mitochondrial proteins to the UPS machinery. In contrast, low
levels of ROS reduce the activity of cytosolic protein degradation pathways
(UFD and N-end rule pathway), which might further strengthen MAD by
increasing the capacity of both conjugation and degradation processes at the
mitochondrial outer membrane. Thus, the general effect of low oxidative stress
on the UPS reflects a conserved mitochondrial surveillance response (MSR).
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bolism, downregulation of respiratory chain function, mitochon-
drial fission, or mitochondrial UPR demonstrated a general effect
of oxidative andmetabolic stress on ubiquitin-dependent protein
turnover both in C. elegans and in human metabolic diseases
(Figures 5A, 5D, 5E, 6A, 6C, 6D, S4E, and S4F).
Surprisingly, compared to the stabilization of UFD and N-end
rule substrates, the turnover of mitochondrial proteins via the
MAD pathway remained unchanged from a patient with severe
IVA based on homozygosity for c.IVS4+2T > C (Figures 6C, 6D,
and 6F). Thus, in contrast to MAD, protein turnover in the cytosol
is less efficient under mild oxidative stress conditions. Accord-
ingly, ROS-induced degradation defects of ivd-1 and acs-19 or
antimycin A-treated MelJuSo cells can be suppressed by the
antioxidant NAC, which does not compensate for loss of the
MAD regulator CDC-48 (Figures 4E and 6B). Furthermore, cdc-
48(RNAi) aggravates the turnover defects of ivd-1(hh6) and
acs-19(hh5) mutants, thereby supporting the idea of differently
affected proteolytic pathways (Figures S5A and S5B). Defects
in ubiquitin-dependent degradation caused by mitochondrial
stress do not correlate with reduced viability of worm mutants.
Conversely, the acs-19 mutant exhibits increased lifespan
compared to wild-type worms, which can be suppressed by
NAC (Figures 7A and S5C). This observation suggests that bene-
ficial consequences of mild oxidative stress are not overruled
by limited UPS function (Figure 7A; Table S4). Loss of HECD-1,
however, results in constitutively increased ROS level (Fig-
ure S3D), and reduced longevity which supports the idea that
the HECT E3 ligase provides an overlapping function both in
cytosolic and mitochondrial protein turnover related to the role
of HUWE1 (Leboucher et al., 2012; Liu et al., 2011).
Conceptually, our work identified a link betweenmitochondrial
stress and UPS activity. This observation appears contradictory
with regard to the inducible MAD pathway that degradesCunfolded mitochondrial proteins in response to high oxidative
and metabolic stress. However, specific reduction of prominent
ubiquitin-mediated degradation pathways in the cytosol might
further strengthenMAD by increasing the capacity of both conju-
gation and degradation processes at the mitochondrial outer
membrane (Figure 7B). Indeed, overexpression of the 19S cap
subunit rpn-6 known to trigger both the integrity and activity of
the 26S proteasome is able to compensate cytosolic ubiquitin-
dependent turnover defects (Figure 3E) (Vilchez et al., 2012).
Thus, it is intriguing to speculate that mild oxidative stress con-
ditions reinforce MAD to maintain mitochondrial homeostasis
and cellular surveillance.
Defects in mitochondrial metabolism are closely linked to
chronic human diseases including cancer and neurodegenera-
tion (Wallace, 2005). So far, changes in UPS function have not
been specifically linked to mitochondrial diseases. Analyzing
different human metabolic disorders, we noticed a strict correla-
tion betweenmitochondrial failure and proteolytic defects similar
to the observations inC. elegans (Figures 6C, 6D, S4E, and S4F).
According to our model, the inhibition of cytosolic UPS path-
ways might contribute to survival on a cellular level but does
not compensate the organismal consequences of the different
mitochondrial defects (Figure 7B). In this regard, sustainedmain-
tenance of defective mitochondria could actually be the reason
for disease pathology of otherwise harmful mutations. Patients
with IVA specifically suffer from an accumulation of isovaleryl-
CoA derivatives based on a defect in IVD, resulting in acidifica-
tion of blood and urine (Table S3). The accumulation of both
UFD and N-end rule substrates is closely correlated with
increased ROS level and the severity of the IVA disease pathol-
ogy (Figures 6C–6E). It is intriguing to speculate that changed
UPS activity potentiates development and progression of meta-
bolic diseases through a conserved mitochondrial surveillance
response (MSR) (Figure 7B). Thus, the response mechanisms
that limit ubiquitin-dependent protein turnover provide a target
for therapeutic intervention of chronic metabolic diseases
caused by mitochondrial failure.
EXPERIMENTAL PROCEDURES
Strains
Worms were handled according to standard procedures and grown at 15C or
20C unless otherwise stated. Mutations and transgenes used in this study
are listed by chromosomes as follows: cdc-48.1(tm544)II, unc-119(ed4)III,
sur-5::UbV-GFPIII, acs-19(tm4853)III, hecd-1(tm2371)IV, sur-5::mCherry, sur-
5::K29,48RUb-GFP, sur-5::GFP. The Bristol strain N2 was used as wild-type
and CB4856 Hawaii for mutant mapping studies. The strains AGD614 N2,
uthEx633 [Pmyo-3::GFP] and AGD598 N2, uthEx556 [Psur-5::rpn-6.1,Pmyo-
3::GFP], VK1879 vkEx1879 [Pnhx-2cpl-1
W32AY35A::YFP;Pmyo-2mCherry],
CL2166 dvIs19 [pAF15(gst-4::GFP::NLS)], SJ4005 zcIs4 [hsp-4::GFP]V,
SJ4100 zcIs13[hsp-6::GFP]V, BC10060 dpy-5(e907); sEX884[hsp-70::GFP+
pCeh361] were kind gifts from A. Dillin, C.J. Luke, C. Link, and D. Ron,
respectively.
Mutagenesis
The strain PP608 hhIs64 [unc-119(+); sur-5::UbV-GFP]III; hhIs73 [unc-119(+);
sur-5::mCherry] was grown at 15C. A total of 10,000 L4-staged hermaphro-
dites were treated with 50 mM EMS for 4 hr at room temperature. Worms
were grown to day 1 of adulthood and bleached in sodium hypochloride solu-
tion, and 86,000 F1 worms obtained were cultured at 15C until day 1 of adult-
hood. Worms were staged again by bleaching in sodium hypochlorite and the
F2 population (16,250 F2s) analyzed with a fluorescence stereomicroscope atell Metabolism 19, 642–652, April 1, 2014 ª2014 Elsevier Inc. 649
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selected to new plates and cultured at 15C. For further experiments ivd-
1(hh6) and acs-19(hh5) were outcrossed six times against wild-type worms.
Mutant Identification
Mutants obtained by EMS mutagenesis were analyzed for chromosome link-
age (ivd-1, acs-19 and hecd-1) and interval mapping (ivd-1, acs-19) according
to Davis et al. (2005). Here, mutant worms were crossed with CB4856, and
Ub-GFP stabilization served as marker for the mutant phenotype. Themutants
were sequenced by WGS as described recently (Doitsidou et al., 2010; Sarin
et al., 2008). For acs-19 and ivd-1 the mutations were verified after six times
outcrossing against wild-type worms, selection of mutant phenotype, and
Sanger sequencing of the mutation.
RNAi
RNA interference was performed using the feeding method (Segref and
Hoppe, 2012). Typically, worms were treated with RNAi from L1 stage and
the phenotype observed during day 1 of adulthood unless otherwise stated.
For ivd-1, acs-19, and hecd-1 RNAi, stabilization of Ub-GFP served as an
internal control for RNAi efficiency.
Generation of Transgenic C. elegans
The original mutant strains obtained after EMS mutagenesis were injected
with 10 ng/mL of the fosmids (WRM0620aH08 [for acs-19] or WRM061bH04
[for ivd-1]) and 100 ng/mL of pRF4 (rol-6(su1006 dm)). Rescued F1 animals
were analyzed at day 1 of adulthood for expression of GFP.
In Vivo Imaging
In vivo imaging was performed as described recently (Segref and Hoppe,
2012).
Immunoblotting
Worms were lyzed in SDS sample buffer and equal volumes applied to SDS-
PAGE as described recently (Segref and Hoppe, 2012). Western blotting
was performed using antibodies against GFP (Clontech), ubiquitin (Upstate),
mCherry (Abcam), tubulin (Sigma), and IVD (R. Ensenauer).
Polyubiquitylation
To investigate the polyubiquitylation status, worms were grown at 20C till day
1 of adulthood. Worms were washed off the plates with 13M9 buffer, settled
on ice, and the worm pellet lyzed in SDS sample buffer containing 10mMNEM
at 95C for 4 min. Worms were analyzed by western blotting using an antibody
against ubiquitin and tubulin as loading control. For polyubiquitylation of tissue
culture cells, cells grown at similar densities were collected in SDS sample
buffer and subjected to western blotting.
Quantification of ROS in Nematodes by MitoTracker Red
Fluorescence
Nematodes were synchronized and either grown to day 1 adult stage or L1
larvae and treatedwith RNAi against, ivd-1, acs-19, or the empty control vector
for 48 hr. Worms were washed off the plates with S-basal buffer (pH 6) and
allowed to settle by centrifugation (2003 g, 1 min). The worm pellet was trans-
ferred to plates spotted with 500 ml heat-inactivated OP50 (65C, 30 min)
mixed with 100 ml MitoTracker Red CM-H2X stock solution (100 mM; freshly
prepared) for 2 hr at 20C. To remove excess dye from the gut, the nematodes
were washed with S-basal buffer three times and transferred to new plates
with either OP50 or RNAi for 1 hr at 20C. A total of 100 ml worm suspension
aliquots in S-basal buffer were distributed into eight wells/condition of a
96-well FLUOTRAC plate (Greiner Bio-One,). Fluorescence (ex, 570 nm; em,
610 nm) was measured in a plate reader (FLUOstar Optima, BMG Labtech).
To normalize the fluorescence signal, the protein content in the remaining
worm suspension was determined using the Bradford assay.
Quantification of Hydrogen Peroxide Production of Nematodes by
AmplexRed Fluorescence
Wormswere treatedwith RNAi against ivd-1, acs-19, or control vector with and
without NAC (final 10 mM) for 48 hr beginning at L1 stage. As internal positive
control, we incubated one part of the control worms on plates containing anti-650 Cell Metabolism 19, 642–652, April 1, 2014 ª2014 Elsevier Inc.mycin A (final 1 mM) for 2 hr right before the measurement. Worms were
removed from plates with sodium-phosphate buffer (50 mM, pH 7.4) and
washed twice. Ampliflu (Sigma-Aldrich) solution (final concentration 10 mM)
and horse-radish peroxidase (Sigma-Aldrich, final concentration 10 mU/ml)
were added to the nematodes. Measurement was carried out in 96-well
Fluotrac plates (Bio Greiner One) using a microplate reader (FLUOstar Optima,
BMG Labtech) and filters for excitation at 544 nm and emission at 590 nm for
20 min at 20C.
Measurement of Mitochondrial ROS in Primary Human Fibroblasts
Primary human fibroblast cells were incubated with 5 mM MitoSOX Red
(Molecular Probes) for 30 min and ROS levels determined by imaging the cells
with a Zeiss Meta 510 Confocal Laser Scanning Microscope (Abs., 514 nm;
Em., 561 nm). Fluorescent images of MitoSOX-stained cells were taken with
a 203 objective. Images were processed with ImageJ 1.48e software, and
mean fluorescence intensities of single cells are shown on the graph.
Stress Tests
NGM plates containing 3 mM rotenone (Sigma, 100 mM stock in DMSO), 2 mM
antimycin A (Sigma, 10 mM stock in 100% ethanol), or 0.2 mM sodium azide
(Sigma, 200 mM stock in water, (only DMSO, ethanol, or water was added
to the respective control plates) were prepared freshly before the start of the
experiment. The strain PP563 hhIs64 [unc-119(+); sur-5::UbV-GFP]III was
grown from L4 stage for 12 hr at 20C and analyzed for expression of Ub-GFP
by microscopy and western blotting. To analyze development, staged
young adult worms were placed on NGM plates with ethanol as control or
with 2 mM antimycin A and allowed to lay eggs for 4 hr. The adult worms
were removed from the plates and the offspring grown at 15C for 5 days.
Worms were examined for their developmental stage and grouped into adult
worms or worms that had reached only a larval stage. For treatment with
antioxidants, NGM plates containing NAC (Sigma) (500 mM stock in water)
were prepared freshly. L1-staged mutants worms expressing sur-5::UbV-
GFP were added to the plates and grown at 15C till day 1 of adulthood.
Worms were collected in SDS sample buffer and analyzed by western blotting
for expression of Ub-GFP.
ATP Measurements
Two hundred day 1 adult hermaphrodite worms grown at 15Cwere collected,
washed four times in 13 M9 buffer, and frozen at 80C before extract prep-
aration. ATP levels were measured using the ATP bioluminescence kit HSII
(Roche) according to the manufacturer’s instruction. In brief, worms were
lyzed in 500 ml lysis buffer provided with the kit, kept on ice for 10min with brief
vortexing every 2 min. The lysate was incubated at 95C for 5 min, sonicated
with a microsonicator, and incubated at 95C for 5 min. The lysates were
centrifuged at 13,000 rpm for 2 min at room temperature. Of the lysate, 50 ml
was mixed with 50 ml of the Luminescence reagent provided with the kit
using the Tecan infinite 200 microplate reader. Analysis was performed with
a readout time of 10 s. An ATP curve in the extract was performed to ensure
linearity of the measurement.
Proteasome Activity
Proteasome activity was measured essentially as described previously
(Vilchez et al., 2012).
Lifespan Analysis
Lifespan analysis was performed as described recently (Kuhlbrodt et al.,
2011).
Cell Culture and Transfections
WT and G6930A cells were cultivated in DMEM with Glutamax supplemented
with 5% FCS, 50 mg/ml uridine, 1 mM sodium pyruvate, 100 mg/ml strepto-
mycin, and 100 U/ml penicillin at 37C and 5% CO2. After informed consent
was obtained, primary human IVD fibroblast cell lines were derived from skin
of two children with isovaleric acidemia diagnosed by a disease-related meta-
bolic pattern and homozygous IVD gene mutations, and of a healthy child un-
dergoing inguinal hernia repair that served as a control cell line, with approval
of the Institutional Review Board of the Ludwig-Maximilians-Universita¨t Mu¨n-
chen (Table S3). MelJuSo cells were cultivated in DMEM and fibroblasts in
Cell Metabolism
Mitochondrial Stress Affects UPS ActivityDMEM with Glutamax supplemented with 10% FCS, 100 mg/ml streptomycin,
and 100 U/ml penicillin at 37C and 5% CO2. Transfection was performed in
6 cm dishes using 10 mg of UbG76V-GFP or UbR-GFP (Dantuma et al., 2000)
obtained from N. Dantuma and 5 mg pmCherry-C1 with 10 ml Lipofectamine
2000 (Life Technologies) according to the manufacturer’s instruction. Cells
were collected in SDS sample buffer after 24 hr and analyzed by SDS-PAGE
and western blotting. In the case of Bortezomib treatment, 20 nM Bortezomib
or as control DMSO was added to the culture 6 hr after transfection.
Statistics
Themean ± SD is reported unless otherwise indicated. Statistical comparisons
among groups were determined using two-tailed Student’s t test with a signif-
icance value of p% 0.05.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and five tables and can be
found with this article at http://dx.doi.org/10.1016/j.cmet.2014.01.016.
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